Eric Hatterer

1 Patent

• US121228502024

  Bispecific Gpc3xcd28 and Gpc3xcd3 Antibodies and Their Combination for Targeted Killing of GPC3 Positive Malignant Cells

  Lamkap Bio Gamma AG

  0 cites